Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy-Reference-Cited by-同舟云学术

Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy

Published:2022-01-20 Issue:2 Volume:52 Page:161-173
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Gérard M¹^ORCID,de Boysson H¹²^ORCID,Morello R³,Martin-Silva N¹,Leroux A-C⁴,Dumont A¹²^ORCID,Maigné G¹,Boutemy J¹,Khoy K⁵,Mariotte D⁵^ORCID,Lobbedez T⁶^ORCID,Aouba A¹²^ORCID,Deshayes S¹²^ORCID

Affiliation:

1. Department of Internal Medicine, CHU de Caen Normandie, Caen, France

2. Faculty of Caen, Université de Caen Normandie (UNICAEN), Caen, France

3. Functional Unit of Biostatistics and Clinical Research, CHU de Caen Normandie, Caen, France

4. Department of Nephrology, Centre Hospitalier Mémorial, Saint-Lô, France

5. Department of Immunology, CHU de Caen Normandie, Caen, France

6. Department of Nephrology, CHU de Caen Normandie, Caen, France

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2021.2001929

Reference47 articles.

1. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

2. Classics in medicine

3. Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis

4. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

5. Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis;Frontiers in Pharmacology;2024-05-20

2. Rituximab resistance at 3 months of induction therapy in newly diagnosed or relapsing ANCA-associated vasculitis: A French multicentre retrospective study in 116 patients;Joint Bone Spine;2023-09

3. Allgemeine Empfehlungen für die Behandlung glomerulärer Erkrankungen – 2023;Wiener klinische Wochenschrift;2023-08

4. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV;RMD Open;2023-06